| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Revenues | 1,131,427 | 1,757,463 | 1,227,070 | |
| Cost of goods sold | 433,196 | 682,985 | 330,925 | |
| Gross profit | 698,231 | 1,074,478 | 896,145 | |
| General and administrative expenses | 576,656 | 540,074 | 433,561 | |
| Consulting fees | 130,357 | 76,700 | 35,786 | |
| Total operating expenses | 707,013 | 616,774 | 469,347 | |
| Income (loss) from operations | -8,782 | 457,704 | 426,798 | |
| Net income (loss) | -8,782 | 457,704 | 426,798 | |
| Net loss per common share - basic (in dollars per share) | 0 | 0.01 | 0.01 | |
| Net loss per common share - diluted (in dollars per share) | 0 | 0.01 | 0.01 | |
| Weighted average common shares outstanding - basic (in shares) | 10,979,055 | 43,916,221 | 43,916,221 | |
| Weighted average common shares outstanding - diluted (in shares) | 10,979,055 | 44,336,221 | 44,336,221 | |
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)